Fatty Liver Disease Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Fatty Liver Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 31 trials

Recruiting

Comorbidities Resolution After MGB Surgery and Change in Body Composition

HypertensionNon-Alcoholic Fatty Liver DiseaseSleep Apnea+5 more
All India Institute of Medical Sciences, Bhubaneswar35 enrolled1 locationNCT06015620
Recruiting

"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".

Liver CancerNon-Alcoholic Fatty Liver DiseaseNon Alcoholic Steatohepatitis+4 more
Institut National de la Santé Et de la Recherche Médicale, France800 enrolled1 locationNCT04690972
Recruiting
Not Applicable

Glucagon Resistance in Patients With MASLD and T2DM

Type 2 Diabetes (T2DM)Metabolic Associated Fatty Liver Disease
University of Aarhus24 enrolled1 locationNCT07246421
Recruiting
Phase 4

Quantifying Hepatic Mitochondrial Fluxes in Humans

Non-Alcoholic Fatty Liver DiseaseType 2 DiabetesMitochondrial Metabolism Disorders
The University of Texas Health Science Center at San Antonio60 enrolled2 locationsNCT05305287
Recruiting

Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease

FibrosisNonalcoholic SteatohepatitisNonalcoholic Fatty Liver Disease+1 more
Peking Union Medical College Hospital200 enrolled1 locationNCT05330923
Recruiting
Not Applicable

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

Insulin Sensitivity/ResistanceObesityInsulin Resistance+16 more
Pichamol Jirapinyo, MD, MPH132 enrolled2 locationsNCT06138821
Recruiting

Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease

Liver NeoplasmLiver FibrosisHBV Infection+1 more
Nanfang Hospital, Southern Medical University240 enrolled1 locationNCT07265544
Recruiting

Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases

HealthyObesity, OverweightChronic Kidney Disease+3 more
Chang Gung Memorial Hospital6,266 enrolled1 locationNCT07248371
Recruiting

Liver Disease and Other Systemic Diseases

Hepatocellular CarcinomaHumansTreatment Outcome+7 more
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation15,000 enrolled1 locationNCT04525833
Recruiting

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Lung CancerCancer RiskCancer Predisposition Syndrome+28 more
Dana-Farber Cancer Institute5,000 enrolled1 locationNCT05463796
Recruiting

Cardiovascular Risk in Children With Chronic Conditions Study

Obesity and OverweightLymphomaLeukemia+22 more
Semmelweis University300 enrolled3 locationsNCT07086989
Recruiting

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)

ObesityNon-Alcoholic Fatty Liver DiseaseHealthy+1 more
Bettina Mittendorfer60 enrolled1 locationNCT06571474
Recruiting

Digital Early Warning System for Acute Lung Injury in Liver Surgery

MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Acute Lung Injury(ALI)Liver Cirrhosis+4 more
Beijing Tsinghua Chang Gung Hospital4,000 enrolled1 locationNCT07070362
Recruiting
Early Phase 1

The Gut, Liver And Metabolome in Human Immunodeficiency Virus and Non Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver DiseaseHIVMetabolic-Associated Steatotic Liver Disease
Vanderbilt University Medical Center63 enrolled1 locationNCT06113003
Recruiting
Not Applicable

Effect of Bempedoic Acid on Liver Fat in Individuals With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes

Type 2 DiabetesNon Alcholic Fatty Liver Disease
Medanta, The Medicity, India100 enrolled1 locationNCT06035874
Recruiting
Phase 2

Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver DiseaseImpaired Glucose ToleranceType 2 Diabetes Mellitus+1 more
Yale University60 enrolled1 locationNCT05067621
Recruiting
Not Applicable

OneSTOP (One-Stop Telehealth Obesity Program) for Multidisciplinary Weight Management and Related Comorbidities

HypertensionTelemedicineDyslipidaemia+2 more
Changi General Hospital120 enrolled1 locationNCT06890169
Recruiting

CHronic Hepatopathies Associated with ALcohol Consumption and MetAbolic Syndrome

Hepatocellular CarcinomaNon-Alcoholic Fatty Liver DiseaseNon Alcoholic Steatohepatitis+2 more
Institut National de la Santé Et de la Recherche Médicale, France710 enrolled1 locationNCT05623150
Recruiting
Not Applicable

Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style Intervention

Diabetes MellitusInsulin ResistanceMetabolic Disease+4 more
Chinese University of Hong Kong80 enrolled1 locationNCT03875625
Recruiting

Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals

Non-Alcoholic Fatty Liver DiseaseLow Birth Weight
Steno Diabetes Center Copenhagen300 enrolled1 locationNCT05890365